Ditto - I am getting everything in duplicate
Eleanor
Andy Purkiss-Trew wrote:
Hi Ian and list,
I don't know about rejected postings, as I've not made any recently, but
I am getting two copies of each posting made and the second has gone
through the same server as below:
Received: from ms1.kissei.co.jp ([210.238.65.82]) by
a12536.general.kissei.co.jp (Lotus Domino Release 6.5.4FP2) with
ESMTP id 2007081510253541-2677 ; Wed, 15 Aug 2007 10:25:35 +0900
Received: from ictmailer1.itd.rl.ac.uk (ictmailer1.itd.rl.ac.uk
[130.246.192.56]) by ms1.kissei.co.jp (8.11.6/3.7W) with ESMTP
id l7F1PYJ20264 for <[EMAIL PROTECTED]>; Wed, 15 Aug 2007
10:25:34 +0900
Looks like problem with someone's e-mail system to me.
Andy
On Wed, 2007-08-15 at 11:03 +0100, Ian Tickle wrote:
All - is anyone else getting this response every time they post a
message or is it just me? The received header shows
<[EMAIL PROTECTED]> (ms1.kissei.co.jp [210.238.65.82]).
-- Ian
-----Original Message-----
From: JISCMAIL LISTSERV Server (14.5)
[mailto:[EMAIL PROTECTED]
Sent: 15 August 2007 10:51
To: Ian Tickle
Subject: Rejected posting to [email protected]
Your message is being returned to you unprocessed because
it appears to have
already been distributed to the CCP4BB list. That is, a
message with identical
text (but possibly with different mail headers) has been
posted to the list
recently, either by you or by someone else. If you have
reason to resend this
message to the list (for instance because you have been
notified of a hardware
failure with loss of data), please alter the text of the
message in some way
and resend it to the list. Note that altering the
"Subject:" line or adding
blank lines at the top or bottom of the message is not
sufficient; you should
instead add a sentence or two at the top explaining why you
are resending the
message, so that the other subscribers understand why they
are getting two
copies of the same message.
Disclaimer
This communication is confidential and may contain privileged information intended solely for the named addressee(s). It may not be used or disclosed except for the purpose for which it has been sent. If you are not the intended recipient you must not review, use, disclose, copy, distribute or take any action in reliance upon it. If you have received this communication in error, please notify Astex Therapeutics Ltd by emailing [EMAIL PROTECTED] and destroy all copies of the message and any attached documents.
Astex Therapeutics Ltd monitors, controls and protects all its messaging traffic in compliance with its corporate email policy. The Company accepts no liability or responsibility for any onward transmission or use of emails and attachments having left the Astex Therapeutics domain. Unless expressly stated, opinions in this message are those of the individual sender and not of Astex Therapeutics Ltd. The recipient should check this email and any attachments for the presence of computer viruses. Astex Therapeutics Ltd accepts no liability for damage caused by any virus transmitted by this email. E-mail is susceptible to data corruption, interception, unauthorized amendment, and tampering, Astex Therapeutics Ltd only send and receive e-mails on the basis that the Company is not liable for any such alteration or any consequences thereof.
Astex Therapeutics Ltd., Registered in England at 436 Cambridge Science Park,
Cambridge CB4 0QA under number 3751674
